Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical.
Dengue virus (DEN) causes dengue fever and dengue hemorrhagic fever/dengue shock syndrome, which are major public health problems worldwide. The immune factors that control DEN infection or contribute to severe disease are neither well understood nor easy to examine in humans. In this study, we used wild-type and congenic mice lacking various components of the immune system to study the immune mechanisms in the response to DEN infection. Our results demonstrate that alpha/beta interferon (IFN-alpha/beta) and IFN-gamma receptors have critical, nonoverlapping functions in resolving primary DEN infection. Furthermore, we show that IFN-alpha/beta receptor-mediated action limits initial DEN replication in extraneural sites and controls subsequent viral spread into the central nervous system (CNS). In contrast, IFN-gamma receptor-mediated responses seem to act at later stages of DEN disease by restricting viral replication in the periphery and eliminating virus from the CNS. Mice deficient in B, CD4(+) T, or CD8(+) T cells had no increased susceptibility to DEN; however, RAG mice (deficient in both B and T cells) were partially susceptible to DEN infection. In summary, (i) IFN-alpha/beta is critical for early immune responses to DEN infection, (ii) IFN-gamma-mediated immune responses are crucial for both early and late clearance of DEN infection in mice, and (iii) the IFN system plays a more important role than T- and B-cell-dependent immunity in resistance to primary DEN infection in mice.
Division of Infectious Diseases, School of Public Health, University of California at Berkeley, Berkeley, California 94720, USA.
Sujan
S
Shresta
Jennifer L
JL
Kyle
Heidi M
HM
Snider
Manasa
M
Basavapatna
P Robert
PR
Beatty
Eva
E
Harris
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D003715:Dengue / Q000276:immunology*; D003716:Dengue Virus / Q000145:classification / Q000472:pathogenicity*; D006801:Humans; D016898:Interferon-alpha / Q000378:metabolism; D016899:Interferon-beta / Q000378:metabolism; D007371:Interferon-gamma / Q000378:metabolism; D007372:Interferons / Q000378:metabolism*; D051379:Mice; D020297:Mice, Congenic; D008810:Mice, Inbred C57BL; D017471:Receptors, Interferon / Q000235:genetics / Q000378:metabolism; D012703:Serotyping; D013601:T-Lymphocytes / Q000276:immunology*
D016898:Interferon-alpha; D017471:Receptors, Interferon; D016899:Interferon-beta; D007371:Interferon-gamma; D007372:Interferons